<?xml version="1.0" encoding="UTF-8"?>
<p>Today, almost two decades after the emergence of SARS-CoV, the newly emerging Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is now spreading in pandemic proportions after the first reported case in the city of Wuhan, China on December 2019 [
 <xref rid="B9-pathogens-09-00580" ref-type="bibr">9</xref>]. This coronavirus-associated acute respiratory disease, the Coronavirus 2019 disease (COVID-19), has turned into a serious global health crisis with 6,407,129 infected individuals and 378,270 reported deaths by 2 June 2020. As the virus is vanishing from most industrialized countries in the northern hemisphere, a new spread wave is sweeping South America (SA) under more complex and heterogeneous epidemiological contexts that may favor increased transmission and long-term persistence [
 <xref rid="B10-pathogens-09-00580" ref-type="bibr">10</xref>]. In this sense, monitoring SARS-CoV-2 and an increased testing capacity becomes a critical issue for most South American nations.
</p>
